Skip to main content
. Author manuscript; available in PMC: 2009 Mar 6.
Published in final edited form as: Nucl Med Biol. 2008 Jul;35(5):615–622. doi: 10.1016/j.nucmedbio.2008.04.003

Fig. 3.

Fig. 3

Diagram of a CPCU setup for a synthesis of [18F]fluoroethylbrosylate. Vial 1: 5 mg of Kryptofix2,2,2 in 1 ml of acetonitrile; a 1-ml v-vial. Vial 2: 3 ml of acetonitrile; a 5-ml v-vial. Vial 3: 7 mg of 1,2-ethanediol bis-(4-bromobenzenesulfonate) in 1 ml of acetonitrile; a 1-ml v-vial. Vial 4: 10 ml of diethyl ether; a 10-ml vial. Vial 5: 1 mg of potassium carbonate in 0.6 ml of low F-19 water; a 1-ml vial.